J147 Powder

J147 Powder

Introduction

J147 Powder stands as a dedicated research product, explicitly formulated for scientific exploration and without any implication for human consumption. This powdered form of J147 offers researchers a valuable tool to investigate its unique properties and potential benefits in various research domains.

Key Characteristics

J147, recognized for its distinct pharmacological profile, is a derivative of curcumin and a cyclohexyl-bisphenol A analogue. It has garnered attention for its potential neuroprotective and cognition-enhancing properties, making it a subject of interest in neuroscience and related fields.

Research Applications

J147 Powder finds versatile applications in research domains, providing researchers with a tool to explore its potential benefits, with a specific focus on Alzheimer’s disease, nootropic effects, and mitochondrial function improvement.

Research Benefits

J147 and Alzheimer’s disease

Studies indicate that J147 may possess neuroprotective effects. Research in this domain aims to uncover its mechanisms of action and therapeutic potential in addressing neurodegenerative conditions.

J147 as a Potential Nootropic

Preliminary research suggests that J147 may exhibit nootropic-like properties, potentially influencing cognitive function. Investigations into its impact on memory, learning, and overall cognitive enhancement contribute to understanding its potential as a nootropic compound.

J147 May Enhance Mitochondrial Function

Research indicates that J147 may have a role in improving mitochondrial function. Studies exploring its effects on cellular energy production contribute to our understanding of its potential applications in promoting mitochondrial health.

Summary

J147 Powder, meticulously crafted for research purposes, offers researchers an opportunity to explore its potential benefits in Alzheimer’s disease, as a potential nootropic, and in improving mitochondrial function. The distinct characteristics of J147 make it a promising subject for further exploration in neuroscience and cognitive research.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions.  Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at support@bc9.co.

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Prior M, Dargusch R, Ehren JL, Chiruta C, Schubert D. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer’s disease mice. Alzheimers Res Ther. 2013 May 14;5(3):25. doi: 10.1186/alzrt179. PMID: 23673233; PMCID: PMC3706879. [Read More]
2. Prior M, Dargusch R, Ehren JL, Chiruta C, Schubert D. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer’s disease mice. Alzheimers Res Ther. 2013 May 14;5(3):25. doi: 10.1186/alzrt179. PMID: 23673233; PMCID: PMC3706879. [Read More].
3. Baines, C. P. (2009). The molecular composition of the mitochondrial transition pore. Journal of Molecular Cell Cardiology, 46(6), 850–857. https://doi.org/10.1016/j.micinf.2011.07.011.Inna [Read More].